FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
source: pixabay.com

FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever

A press release from the US Food and Drug Administration (FDA) recently announced the approval of the drug selumetinib (marketed as Koselugo) for the treatment of patients aged two years…

Continue Reading FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
Close Menu